In light of these alarming statistics, and the lack of effective treatment options, a study was conducted to explore the potential of phytochemicals derived from Cannabis sativa L to treat breast and lung cancers caused by abnormal enzymatic activity of EGFR-TKD (PDB ID:1M17). The gene discussed is EGFR; the disease is lung carcinoma.